Morgan Stanley
IMA

Morgan Stanley’s ImageneBio Inc IMA Stock Holding History

Morgan Stanley’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.4K Sell
16,678
-1,661
-9% -$9.38K ﹤0.01% 6263
2026
Q1 		$91.7K Buy
18,339
+7,568
+70% +$49.1K ﹤0.01% 6200
2025
Q4 		$74.3K Buy
10,771
+9,485
+738% +$70.3K ﹤0.01% 6305
2025
Q3 		$10.5K Sell
1,286
-999
-44% -$13.2K ﹤0.01% 6888
2025
Q2 		$36.7K Buy
2,285
+1,237
+118% +$18.2K ﹤0.01% 6460
2025
Q1 		$16.1K Sell
1,048
-236
-18% -$4.07K ﹤0.01% 6643
2024
Q4 		$25.3K Hold
1,284
– – ﹤0.01% 6501
2024
Q3 		$26.6K Sell
1,284
-2,122
-62% -$42.9K ﹤0.01% 6408
2024
Q2 		$67.4K Sell
3,406
-714
-17% -$12.6K ﹤0.01% 6090
2024
Q1 		$70.2K Sell
4,120
-1,595
-28% -$29K ﹤0.01% 6113
2023
Q4 		$135K Buy
5,715
+4,405
+336% +$144K ﹤0.01% 5830
2023
Q3 		$68K Buy
1,310
+61
+5% +$3.67K ﹤0.01% 6038
2023
Q2 		$98.3K Buy
1,249
+125
+11% +$8.96K ﹤0.01% 5961
2023
Q1 		$46.5K Buy
1,124
+818
+267% +$37.6K ﹤0.01% 6314
2022
Q4 		$9.76K Sell
306
-3,987
-93% -$127K ﹤0.01% 6948
2022
Q3 		$183K Sell
4,293
-1,966
-31% -$114K ﹤0.01% 5762
2022
Q2 		$332K Buy
6,259
+5,183
+482% +$286K ﹤0.01% 5631
2022
Q1 		$78K Buy
1,076
+64
+6% +$6.8K ﹤0.01% 6467
2021
Q4 		$153K Buy
1,012
+743
+276% +$121K ﹤0.01% 6204
2021
Q3 		$41K Buy
269
+239
+797% +$34.7K ﹤0.01% 6801
2021
Q2 		$5K Buy
+30
New +$6.62K ﹤0.01% 7379

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

Morgan Stanley's IMA Position: Q2 2026 in Review

Morgan Stanley reduced its ImageneBio Inc (IMA) stake by 9.1% in Q2 2026, selling an estimated $9.38K and leaving 16,678 shares worth $98.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6263.

Morgan Stanley first reported a position in IMA in Q2 2021 and has held it in 21 quarters since. The position peaked at $332K in Q2 2022. 35 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

  • Morgan Stanley held 16,678 shares of ImageneBio Inc worth $98.4K as of Q2 2026.
  • Morgan Stanley sold 1,661 ImageneBio Inc shares in Q2 2026, an estimated $9.38K.
  • ImageneBio Inc made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6263 holding.
  • Morgan Stanley first reported a position in ImageneBio Inc in Q2 2021 and has held it in 21 quarters since.
  • Morgan Stanley's ImageneBio Inc position peaked at $332K in Q2 2022.
  • 35 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.